World Wires · story 12493 · unverified · 1 source(s)

Kailera Therapeutics Presents New Clinical Data at EASD 2026 Annual Meeting

Kailera announced Phase 1 data for ribupatide injection at EASD.

Open in the desk

Coverage

• Kailera Therapeutics Presents New Clinical Data at EASD 2026 Annual Meeting GlobeNewswire: public companies · tier D · clear net · 2026-10-01 10:45 UTC

What this site indexes